LATS suppresses mTORC1 activity to directly coordinate Hippo and mTORC1 pathways in growth control

The Hippo and mammalian target of rapamycin complex 1 (mTORC1) pathways are the two predominant growth-control pathways that dictate proper organ development. We therefore explored potential crosstalk between these two functionally relevant pathways to coordinate their growth-control functions. We f...

Full description

Saved in:
Bibliographic Details
Published inNature cell biology Vol. 22; no. 2; pp. 246 - 256
Main Authors Gan, Wenjian, Dai, Xiaoming, Dai, Xiangpeng, Xie, Jun, Yin, Shasha, Zhu, Junjie, Wang, Chen, Liu, Yuchen, Guo, Jianping, Wang, Min, Liu, Jing, Hu, Jia, Quinton, Ryan J., Ganem, Neil J., Liu, Pengda, Asara, John M., Pandolfi, Pier Paolo, Yang, Yingzi, He, Zhigang, Gao, Guangping, Wei, Wenyi
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.02.2020
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The Hippo and mammalian target of rapamycin complex 1 (mTORC1) pathways are the two predominant growth-control pathways that dictate proper organ development. We therefore explored potential crosstalk between these two functionally relevant pathways to coordinate their growth-control functions. We found that the LATS1 and LATS2 kinases, the core components of the Hippo pathway, phosphorylate S606 of Raptor, an essential component of mTORC1, to attenuate mTORC1 activation by impairing the interaction of Raptor with Rheb. The phosphomimetic Raptor-S606D knock-in mutant led to a reduction in cell size and proliferation. Compared with Raptor +/+ mice, Raptor D/D knock-in mice exhibited smaller livers and hearts, and a significant inhibition of elevation in mTORC1 signalling induced by Nf2 or Lats1 and Lats2 loss. Thus, our study reveals a direct link between the Hippo and mTORC1 pathways to fine-tune organ growth. The Hippo and mTORC1 pathways regulate growth control for proper organ development. Here, Gan et al. find that the Hippo pathway kinases LATS1 and LATS2 phosphorylate the mTORC1 component Raptor to attenuate mTORC1 activation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
W.G. and W.W. designed the experiments. W.G. and X.M.D. performed the experiments with assistance from X.P.D., S.Y., J.G., M.W., J.L. J.H., R.J.Q., N. J. G. and P.L. J.M.A. performed the LC-MS/MS metabolomic profiling and mass spectrometry analysis of Raptor S606 phosphorylation. J.X., J.Z., C.W., Y.L., Y.Y, Z.H. and G.G helped to design and perform the experiments on AAV-mediated depletion of Nf2 and Lats1/2. W.W. and P.P.P supervised the study. W.G. and W.W. wrote the manuscript. All authors commented on the manuscript.
Author contributions
ISSN:1465-7392
1476-4679
DOI:10.1038/s41556-020-0463-6